The risks of indiscriminate use of Femproporex as an appetite inhibitor: a review. Research, Society and Development, [S. l.], v. 10, n. 13, p. e35101321246, 2021. DOI: 10.33448/rsd-v10i13.21246. Disponível em: https://rsdjournal.org/rsd/article/view/21246. Acesso em: 5 dec. 2025.